PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-65.79%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
No Data
No Data available this quarter, please select a different quarter.
143.99%
Other expenses change of 143.99% versus flat Healthcare costs. Walter Schloss would verify efficiency.
-60.41%
Operating expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-60.41%
Total costs reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
2.95%
Interest expense change of 2.95% versus flat Healthcare costs. Walter Schloss would verify control.
-100.00%
D&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency.
-109.95%
EBITDA decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
62.96%
Income change of 62.96% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
-184.33%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
47.99%
Income change of 47.99% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
387.82%
Tax expense change of 387.82% versus flat Healthcare. Walter Schloss would verify strategy.
53.00%
Income change of 53.00% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
52.84%
EPS change of 52.84% versus flat Healthcare. Walter Schloss would verify quality.
52.84%
Diluted EPS change of 52.84% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.